Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04731077 · ClinicalTrials.gov registry record · NA
Avenir Complete Post-Market Clinical Follow-Up Study
A NA study of Osteoarthritis, Hip and Avascular Necrosis of the Femoral Head, sponsored by Zimmer Biomet.
- Active
- Registry status
- NA
- Development phase
- 275
- Enrollment target
- 9
- Study locations
NCT04731077: Active NA study of Osteoarthritis, Hip and Avascular Necrosis of the Femoral Head, sponsored by Zimmer Biomet.
NCT04731077 is a NA study of Osteoarthritis, Hip and Avascular Necrosis of the Femoral Head that is active but no longer recruiting, run by Zimmer Biomet. The registered enrollment target is 275 participants, below the 1,260-participant average among 20 other Osteoarthritis, Hip trials with a reported enrollment target (78% lower). The trial reports 9 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04731077, a NA study of Osteoarthritis, Hip and Avascular Necrosis of the Femoral Head, is active but no longer recruiting, sponsored by Zimmer Biomet.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 275 participants
- Enrollment target
- 9
- Study locations
Study Summary
The main objectives of this study are to confirm the long-term safety, performance and clinical benefits the Avenir Complete femoral stem and its instrumentation when used in primary total, hemi, and revision hip arthroplasty.
Primary Outcome
Survival is classified as removal of the study device for any reason
Conditions Studied
Interventions
- DEVICE Avenir Complete Femoral Stem
Study Locations (9)
Other
- Copenhagen University Hospital, Hvidovre - Copenhagen
- Okayama City Hospital - Okayama
- Sykehuset Innlandet HF - Tynset
- Sahlgrenska University Hospital - Molndal - Mölndal
Mississippi
- Mississippi Sports Medicine and Orthopaedic Center PLLC - Jackson
Missouri
- Heartland Regional Medical Center d.b.a. Mosaic Life Care - Saint Joseph
Oregon
- Orthopedic & Fracture Clinic, PC - Portland
Tokyo
- Nissan Tamagawa Hospital - Setagaya-Ku
South Holland
- Ikazia Ziekenhuis - Rotterdam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 275 participants |
| Start Date | 2021-09-27 |
| Est. Completion | 2036-06-01 |
| Phase | NA |
What the registry record for NCT04731077 still lists
NCT04731077 is an interventional study that assigns participants to a tested intervention. The registered 275 participants enrollment target is mid-sized for trials with a published cap, below the 1,260-participant average among 20 other Osteoarthritis, Hip trials with a reported enrollment target (78% lower).
The record links to 4 conditions, with Osteoarthritis, Hip appearing as the primary indexed condition, and to 1 intervention - of which Avenir Complete Femoral Stem is the first listed.
NCT04731077 lists 9 locations in 6 states (Other, Mississippi, Missouri).
Frequently Asked Questions
What is clinical trial NCT04731077 about?
NCT04731077 is a clinical study titled "Avenir Complete Post-Market Clinical Follow-Up Study". The main objectives of this study are to confirm the long-term safety, performance and clinical benefits the Avenir Complete femoral stem and its instrumentation when used in primary total, hemi, and revision hip arthroplasty.
What is the current status of trial NCT04731077?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 275 participants. The study started on 2021-09-27. Estimated completion is 2036-06-01.
What conditions does trial NCT04731077 study?
This clinical trial studies the following conditions: Osteoarthritis, Hip, Avascular Necrosis of the Femoral Head, Avascular Necrosis of Hip, Post-traumatic; Arthrosis.
What interventions are being tested in trial NCT04731077?
The interventions under investigation include: Avenir Complete Femoral Stem (DEVICE).
Who is sponsoring clinical trial NCT04731077?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04731077 being conducted?
This trial has 9 study locations across Mississippi, Missouri, Oregon, Tokyo, South Holland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis, Hip
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04731077's enrollment target sits among peer trials
275 9th of 20 higher than 12 of 20 other Osteoarthritis, Hip trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis, Hip trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Safety and Effectiveness of the HIT Reverse HRS
RECRUITING · NA
-
Non-invasive Evaluation of Upper and Lower Body Function With Showmotion
RECRUITING · NA
-
G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study
RECRUITING · NA
-
Outcomes of Low-Impact Exercise Program for People With Ankle, Knee, and/or Hip Pain
RECRUITING · NA
-
Early Feasibility Study of Cartilage Defect Repair
RECRUITING · NA
-
Adipose-Derived Biocellular Regenerative Therapy for Osteoarthritis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269190 · 275 participants · NA
Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing Surgery
- NCT01900132 · 275 participants · NA
Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers
- NCT04104776 · 275 participants · Phase 1
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- NCT04765150 · 275 participants
Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI